Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The platelet calcium-dependent activation machinery is a complex signaling network responsible for regulating the rapid increase in cytosolic calcium ([Ca2+]i) required for platelet thrombus formation (Bergmeier & Stefanini, 2013). This machinery primarily operates through store-operated calcium entry (SOCE), where the depletion of calcium from the dense tubular system (DTS) is sensed by Stromal Interaction Molecule 1 (STIM1). STIM1 then translocates to the plasma membrane to activate Orai1, a highly selective calcium release-activated calcium (CRAC) channel, allowing for sustained calcium influx (Braun et al., 2009). This elevation in calcium levels is essential for key platelet functions, including the activation of the integrin alphaIIbbeta3, alpha and dense granule secretion, and phosphatidylserine exposure for procoagulant activity (Varga-Szabo et al., 2008). Because this pathway is crucial for stabilized thrombus formation but less critical for initial hemostasis, it represents an attractive target for anti-thrombotic therapy with a potentially reduced bleeding risk compared to traditional anticoagulants. Pharmacological inhibitors targeting Orai1 or STIM1, such as CM4620 or GSK-7975A, are being explored to treat conditions like arterial thrombosis and ischemic stroke (Stegner et al., 2017). However, challenges remain regarding the potential for off-target effects on the immune system, as SOCE is also vital for T-cell activation and overall immune competence (Feske, 2007).
Inhibition of store-operated calcium entry (SOCE) by blocking Orai1 channels or preventing the interaction between the calcium sensor STIM1 and the pore-forming subunit Orai1, thereby preventing the sustained elevation of intracellular calcium necessary for platelet aggregation and thrombus stabilization.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Platelet calcium-dependent activation machinery.